Prostate Cancer - Results from #2300

Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT. August 22, 2023

Persistent organic pollutants promote aggressiveness in prostate cancer. August 22, 2023

Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy. August 22, 2023

Proton Therapy for the Management of Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center. August 22, 2023

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial August 21, 2023

Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer August 21, 2023

The impact of race on survival in metastatic prostate cancer: a systematic literature review. August 21, 2023

Prostagram MRI in a Screening Population: PI-RADS or Likert? August 21, 2023

Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study. August 21, 2023

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer. August 21, 2023

Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers. August 21, 2023

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases. August 21, 2023

Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer. August 21, 2023

Plain Language Summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide? August 18, 2023

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. August 18, 2023

18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study. August 18, 2023

SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression. August 18, 2023

Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis. August 18, 2023

Club-like cells in proliferative inflammatory atrophy of the prostate. August 18, 2023

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. August 18, 2023

Page 116 of 1439